GlassScriptPhysician profile
Catherine W Bailey
NPI 1730470402
$5,186.54
in general payments reported to CMS, 2019-2025
23 companies · $3,619 in 2025
The $3,619 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $225 · 2021: $199 · 2022: $204 · 2023: $244 · 2024: $455 · 2025: $3,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $951 · Travel and Lodging: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $951.40 |
| Travel and Lodging | $366.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,533.59 | 2024-2025 | |
| Abbvie INC. | $426.78 | 2019-2025 | Liletta |
| Hologic Sales and Service, LLC | $210.48 | 2023-2025 | Acessa Provu System, Aptima, Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $142.06 | 2019-2023 | |
| Pfizer INC. | $142.04 | 2019-2024 | |
| Minerva Surgical, INC | $108.48 | 2020 | |
| Coopersurgical, INC. | $89.62 | 2019-2025 | Paragard T 380a |
| Biogen, INC. | $84.82 | 2024-2025 | Zurzuvae |
| Boston Scientific Corporation | $63.63 | 2024-2025 | Bulkamid |
| Therapeuticsmd, INC. | $58.63 | 2019-2021 | |
| Astellas Pharma US INC | $54.80 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $49.00 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $44.32 | 2022-2025 | |
| Organon LLC | $31.85 | 2021-2023 | Jada System |
| Alexion Pharmaceuticals, INC. | $24.30 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.57 | 2023 | Exparel |
| Avion Pharmaceuticals | $18.46 | 2020 | |
| Exact Sciences Corporation | $16.87 | 2024 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $15.37 | 2019 | |
| Millicent US INC | $13.10 | 2020 | |
| Lupin INC. | $12.94 | 2020 | |
| Mission Pharmacal Company | $12.30 | 2019 | |
| Allergan, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.